Loading...
cGMP modulation therapeutics for sickle cell disease
Sickle cell disease (SCD) is an inherited disease caused by the production of abnormal hemoglobin (Hb) S, whose deoxygenation-induced polymerization results in red blood cell (RBC) sickling and numerous pathophysiological consequences. SCD affects approximately 300,000 newborns worldwide each year a...
Na minha lista:
| Udgivet i: | Exp Biol Med (Maywood) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6405827/ https://ncbi.nlm.nih.gov/pubmed/30691292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370219827276 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|